Dr. Stephen Salloway and his team at the Butler Hospital Memory and Aging Program are conducting groundbreaking research, including the new Atlas of Retinal Imaging Study (ARIAS)—launching in the spring of 2019—to create a reference library of retinal imaging across the Alzheimer’s Disease spectrum. The team is also testing new biomarkers and medications for the prevention and early intervention for AD, including:

• Cutting edge fluid and imaging biomarkers and novel cognitive assessments that use machine learning to study the evolution of AD pathophysiology and determine AD risk and disease stage.
• Targeted treatments such as BACE inhibitors and monoclonal antibodies, alone and in combination, to lower amyloid plaques and neurofibrillary tangles.